Megan Kruse

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Genomic profiling can identify targetable mutations; however, the impact of tissue-based genomic profiling on clinical decision making for patients with metastatic breast cancer has not been well(More)
  • 1